Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant

Explore clinical trials studying Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant trial results

Completed

Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients

NCT01544491

Conditions: Death, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +1 more
Locations: Novartis Investigative Site Los Angeles, California, United States

Novartis Investigative Site Ann Arbor, Michigan, United States

Novartis Investigative Site St Louis, Missouri, United States

Novartis Investigative Site Santa Fe, Argentina

View all 31 locations

View Trial Details

Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant

Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant trial results

Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients

Related conditions